More can be less
SMN1 gene duplications are associated with sporadic ALS
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Both amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) fall within the spectrum of motor neuron diseases. Chromosome 5 SMA, a leading cause of infant death, is characterized by lower motor neuron degeneration without signs of upper motor neuron involvement. In this issue of Neurology®, Blauw et al.1 provide firm evidence that duplications of the SMN1 (“survival of motor neuron”) gene, which is the gene that is deleted or mutated in SMA, are an important risk factor for sporadic ALS. A brief review of the genetics of ALS and SMA enables us to better appreciate the authors' findings.
ALS occurs sporadically, but is familial in 10%. Approximately 20% of familial cases are caused by autosomal dominant and rarely recessive mutations in SOD1 (superoxide dismutase 1). SOD1 mutations have also been described in about 2% of sporadic cases. Mutations in genes such as the TARDBP (TAR DNA-binding protein; TDP-43), FUS/TLS (fused-in-sarcoma/translocated in liposarcoma), ANG (angiogenin), VAPB (vesicle-associated membrane protein B), OPTN (optineurin), and others have been observed mostly in familial patients. Further, mutations in 3 genes, ALS2 (alsin), SETX (senataxin), and sigma R1 (sigma-1 receptor), have been reported in juvenile ALS families. Although environmental/toxic exposures, autoimmune, infectious, and systemic processes may play a role in ALS, direct causation has not …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.